BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
Copyright: ©Author(s) 2026.
World J Methodol. Jun 20, 2026; 16(2): 115003
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.115003
Table 1 Comparison of baseline characteristics between the two groups, n (%)/mean ± SD


Experimental group
Control group
t/χ2
P value
Age (years)66.84 ± 7.9866.32 ± 10.870.170.87
GenderMale12 (63.16) 10 (52.63) 0.430.51
Female7 (36.84) 9 (47.37)
Smoking7 (36.84) 6 (31.58) 0.120.73
ComorbiditiesHypertension8 (42.11) 7 (36.84) 0.110.74
Diabetes7 (36.84) 6 (31.58) 0.120.73
Coronary heart disease5 (26.32) 4 (21.05) 0.150.70
Chronic renal insufficiency8 (42.11) 5 (26.32) 1.050.31
Fontaine stageStage I00
Stage II6 (31.58) 5 (26.32) 0.130.72
Stage III8 (42.11) 10 (52.63) 0.420.52
Stage IV5 (26.32) 4 (21.05) 0.150.70
Ankle-brachial-pressure-index0.26 ± 0.220.30 ± 0.23-0.540.59
Lesion locationIliac artery4 (21.05) 7 (36.84) 1.150.28
Femoropopliteal artery13 (68.42) 7 (36.84) 3.80.051
Infrapopliteal artery9 (47.37) 13 (68.42) 1.730.19


Write to the Help Desk